InvestorsObserver
×
News Home

Where Does Context Therapeutics Inc (CNTX) Stock Fall in the Biotechnology Field After It Has Gained 25.00% This Week?

Monday, June 05, 2023 11:54 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does Context Therapeutics Inc (CNTX) Stock Fall in the Biotechnology Field After It Has Gained 25.00% This Week?

A rating of 45 puts Context Therapeutics Inc (CNTX) near the middle of the Biotechnology industry according to InvestorsObserver. Context Therapeutics Inc's score of 45 means it scores higher than 45% of stocks in the industry. Context Therapeutics Inc also received an overall rating of 50, putting it above 50% of all stocks. Biotechnology is ranked 16 out of the 148 industries.

Overall Score - 50
CNTX has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on CNTX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Context Therapeutics Inc Stock Today?

Context Therapeutics Inc (CNTX) stock is lower by -14.06% while the S&P 500 is up 0.25% as of 11:35 AM on Monday, Jun 5. CNTX is lower by -$0.18 from the previous closing price of $1.28 on volume of 260,918 shares. Over the past year the S&P 500 has gained 4.17% while CNTX is lower by -34.13%. CNTX lost -$1.11 per share the over the last 12 months. Click Here to get the full Stock Report for Context Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App